---
title: "BOCOM International Holdings Company Keeps Their Buy Rating on BeOne Medicines Ltd (6160)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295328589.md"
description: "In a report released yesterday, from BOCOM International Holdings Company maintained a Buy rating on BeOne Medicines Ltd, with a price target of HK$276.00.Claim 55% Off TipRanks Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks The word on The Street in general, suggests a Strong Buy analyst consensus rating for BeOne Medicines Ltd with a HK$269.21 average price target."
datetime: "2026-08-09T14:35:39.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295328589.md)
  - [en](https://longbridge.com/en/news/295328589.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295328589.md)
generator: "portal-rs"
---

# BOCOM International Holdings Company Keeps Their Buy Rating on BeOne Medicines Ltd (6160)

In a report released yesterday, from BOCOM International Holdings Company maintained a Buy rating on BeOne Medicines Ltd, with a price target of HK$276.00.

### Claim 55% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

The word on The Street in general, suggests a Strong Buy analyst consensus rating for BeOne Medicines Ltd with a HK$269.21 average price target.

### Related Stocks

- [BGNE.US](https://longbridge.com/en/quote/BGNE.US.md)
- [06160.HK](https://longbridge.com/en/quote/06160.HK.md)
- [688235.CN](https://longbridge.com/en/quote/688235.CN.md)
- [03329.HK](https://longbridge.com/en/quote/03329.HK.md)

## Related News & Research

- [BeOne says FDA approves Tevimbra-based first-line regimen for HER2+ gastroesophageal cancer](https://longbridge.com/en/news/296930925.md)
- [BeOne Medicines Ltd (6160) Gets a Buy from CMBC International](https://longbridge.com/en/news/285886964.md)
- [Freeport-McMoRan (FCX): New Buy Recommendation for This Basic Materials Giant](https://longbridge.com/en/news/296794439.md)
- [CSC Financial Reaffirms Their Buy Rating on Binjiang Service Group Co. Ltd. (3316)](https://longbridge.com/en/news/296861671.md)
- [Bernstein Keeps Their Buy Rating on DSV A/S (0JN9)](https://longbridge.com/en/news/296802697.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**